威尼斯569vip游戏生物 威尼斯569vip游戏生物
威尼斯569vip游戏生物
DRAGON SAIL PHARMACEUTICAL

Provide One-stop full cycle antibody drugs

CDMO/CMO Innovative solutions

Focus on antibody drugs

Contract development and Production service (CDMO)

Dragon Sail Pharmaceutical Co., Ltd. is a high-tech enterprise focusing on antibody drug CDMO services, and it is dedicated to providing one-stop services for partners from sequence to IND, clinical sample production to BLA and commercial production of antibody drugs. Dragon Sail Pharmaceutical has built the first cross-free antibody plant in China in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, with a total investment of nearly RMB 700 million and a production scale of up to 12,000L. The site complies with Chinese, American and European GMP standards, and its unique NONCROS® cross-free antibody production platform complies with requirements for co-linear production of multiple products, featuring high overall operational efficiency and cost-effectiveness. Leveraging its integrated biopharmaceutical technology platform, Dragon Sail will accelerate the process of discovery, development and production of biological drugs especially for antibody drugs, empowering partners and benefiting patients.
More
  • 2016 Year
    Founded
  • 6.9 hundred million
    Total investment
  • 6*2000 L
    Max Production Scale
  • 1. Preclinical CMC study
  • 2. Clinical Sample Production
  • 3. BLA
  • 4. Commercial Production
about medicilon
One-stop personal CDMO solution
Preclinical CMC study
drug discovery icon
More
One-stop personal CDMO solution
Clinical Sample Production
Pharmaceutical Research
More
One-stop personal CDMO solution
BLA
Preclinical Research
More
One-stop personal CDMO solution
Commercial Production
Preclinical Research
More

Empowering partners to innovate, reduce costs and optimize efficiency

  • Its business services focus on preclinical pharmacological study, clinical drug manufacturing, regulatory affairs and commercial production of a wide range of biologic drugs, including monoclonal antibodies, bispecific antibodies, fusion proteins and peptides.

    Cooperation

  • Dragon Sail Pharmaceutical continues to provide a full range of CDMO services to biopharmaceutical companies in the industry, empowering partners to work towards a healthy future based on its excellent process development and high quality product delivery capabilities.

    Cooperation

News

More

  • Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development

    More

  • Cooperation · Empowerment | Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development

    More

  • Dragon Sail Pharmaceutical was selected as the public list of smart factory enterprises in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone in 2022

    More
DRAGON SAIL PHARMACEUTICAL

Provide One-stop full cycle antibody drugs

CDMO/CMO Innovative solutions

Focus on antibody drugs

Contract development and Production service (CDMO)

Dragon Sail Pharmaceutical Co., Ltd. is a high-tech enterprise focusing on antibody drug CDMO services, and it is dedicated to providing one-stop services for partners from sequence to IND, clinical sample production to BLA and commercial production of antibody drugs. Dragon Sail Pharmaceutical has built the first cross-free antibody plant in China in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, with a total investment of nearly RMB 700 million and a production scale of up to 12,000L. The site complies with Chinese, American and European GMP standards, and its unique NONCROS® cross-free antibody production platform complies with requirements for co-linear production of multiple products, featuring high overall operational efficiency and cost-effectiveness. Leveraging its integrated biopharmaceutical technology platform, Dragon Sail will accelerate the process of discovery, development and production of biological drugs especially for antibody drugs, empowering partners and benefiting patients.
More
  • 2016 Year
    Founded
  • 6.9 Hundred million
    Total investment
  • 6*1200 L
    Max Production Scale

One-stop personal CDMO solution

Empowering partners to innovate, reduce costs and optimize efficiency

Cooperation

Its business services focus on preclinical pharmacological study, clinical drug manufacturing, regulatory affairs and commercial production of a wide range of biologic drugs, including monoclonal antibodies, bispecific antibodies, fusion proteins and peptides.

Cooperation

Dragon Sail Pharmaceutical continues to provide a full range of CDMO services to biopharmaceutical companies in the industry, empowering partners to work towards a healthy future based on its excellent process development and high quality product delivery capabilities.

News

More

  • Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development111

    More

  • Cooperation · Empowerment | Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development111

    More

  • Dragon Sail Pharmaceutical was selected as the public list of smart factory enterprises in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone in 2022111

    More